Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

SOLESENCE, INC. Director's Dealing 2011

Jan 13, 2011

33563_dirs_2011-01-13_8a663413-2120-41d6-98c3-3375a49a5fd2.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: NANOPHASE TECHNOLOGIES CORPORATION (NANX)
CIK: 0000883107
Period of Report: 2011-01-12

Reporting Person: TYLER W EDWIN (Director)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2011-01-12 Common stock (right to buy) $1.19 A 10000 Acquired 2021-01-12 common stock (10000) Direct

Footnotes

F1: Subject to certain restrictions, beginning on this date, options vest in three equal annual installments.